|
1
|
Richeldi L, Collard HR and Jones MG:
Idiopathic pulmonary fibrosis. Lancet. 389:1941–1952. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Antoniou KM, Hansell DM, Rubens MB, Marten
K, Desai SR, Siafakas NM, Nicholson AG, du Bois RM and Wells AU:
Idiopathic pulmonary fibrosis: Outcome in relation to smoking
status. Am J Respir Crit Care Med. 177:190–194. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Selman M and Pardo A: Revealing the
pathogenic and aging-related mechanisms of the enigmatic idiopathic
pulmonary fibrosis. an integral model. Am J Respir Crit Care Med.
189:1161–1172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giopanou I, Arendt KAM and Stathopoulos
GT: Lung carcinogenesis and fibrosis taken together: Just
coincidence? Curr Opin Pulm Med. 23:290–297. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Antoniou KM, Tomassetti S, Tsitoura E and
Vancheri C: Idiopathic pulmonary fibrosis and lung cancer: A
clinical and pathogenesis update. Curr Opin Pulm Med. 21:626–633.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Duruisseaux M and Esteller M: Lung cancer
epigenetics: From knowledge to applications. Semin Cancer Biol
S1044-579X(17)30166-9. 2017. View Article : Google Scholar
|
|
7
|
Sanders YY, Ambalavanan N, Halloran B,
Zhang X, Liu H, Crossman DK, Bray M, Zhang K, Thannickal VJ and
Hagood JS: Altered DNA methylation profile in idiopathic pulmonary
fibrosis. Am J Respir Crit Care Med. 186:525–535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Antoniou KM, Samara KD, Lasithiotaki I,
Margaritopoulos GA, Soufla G, Lambiri I, Giannarakis I, Drositis I,
Spandidos DA and Siafakas NM: Differential telomerase expression in
idiopathic pulmonary fibrosis and non-small cell lung cancer. Oncol
Rep. 30:2617–2624. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sarchianaki E, Derdas SP, Ntaoukakis M,
Vakonaki E, Lagoudaki ED, Lasithiotaki I, Sarchianaki A,
Koutsopoulos A, Symvoulakis EK, Spandidos DA, et al: Detection and
genotype analysis of human papillomavirus in non-small cell lung
cancer patients. Tumour Biol. 35:3203–3209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Samara KD, Antoniou KM, Karagiannis K,
Margaritopoulos G, Lasithiotaki I, Koutala E and Siafakas NM:
Expression profiles of Toll-like receptors in non-small cell lung
cancer and idiopathic pulmonary fibrosis. Int J Oncol.
40:1397–1404. 2012.PubMed/NCBI
|
|
12
|
Vancheri C: Idiopathic pulmonary fibrosis
and cancer: Do they really look similar? BMC Med. 13:2202015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Antoniou KM, Lasithiotaki I, Symvoulakis
E, Derdas SP, Psaraki A, Spandidos DA, Stathopoulos EN, Siafakas NM
and Sourvinos G: Molecular pathological findings of Merkel cell
polyomavirus in lung cancer: A possible etiopathogenetic link? Int
J Cancer. 133:3016–3017. 2013.PubMed/NCBI
|
|
14
|
Lasithiotaki I, Antoniou KM, Derdas SP,
Sarchianaki E, Symvoulakis EK, Psaraki A, Spandidos DA,
Stathopoulos EN, Siafakas NM and Sourvinos G: The presence of
Merkel cell polyomavirus is associated with deregulated expression
of BRAF and Bcl-2 genes in non-small cell lung cancer. Int J
Cancer. 133:604–611. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vassilakis DA, Sourvinos G, Spandidos DA,
Siafakas NM and Bouros D: Frequent genetic alterations at the
microsatellite level in cytologic sputum samples of patients with
idiopathic pulmonary fibrosis. Am J Respir Crit Care Med.
162:1115–1119. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tomassetti S, Gurioli C, Ryu JH, Decker
PA, Ravaglia C, Tantalocco P, Buccioli M, Piciucchi S, Sverzellati
N, Dubini A, et al: The impact of lung cancer on survival of
idiopathic pulmonary fibrosis. Chest. 147:157–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mizuno K, Mataki H, Seki N, Kumamoto T,
Kamikawaji K and Inoue H: MicroRNAs in non-small cell lung cancer
and idiopathic pulmonary fibrosis. J Hum Genet. 62:57–65. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cushing L, Kuang PP, Qian J, Shao F, Wu J,
Little F, Thannickal VJ, Cardoso WV and Lü J: miR-29 is a major
regulator of genes associated with pulmonary fibrosis. Am J Respir
Cell Mol Biol. 45:287–294. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roderburg C, Urban GW, Bettermann K, Vucur
M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi
M, et al: Micro-RNA profiling reveals a role for miR-29 in human
and murine liver fibrosis. Hepatology. 53:209–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Patel V and Noureddine L: MicroRNAs and
fibrosis. Curr Opin Nephrol Hypertens. 21:410–416. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luna C, Li G, Qiu J, Epstein DL and
Gonzalez P: Role of miR-29b on the regulation of the extracellular
matrix in human trabecular meshwork cells under chronic oxidative
stress. Mol Vis. 15:2488–2497. 2009.PubMed/NCBI
|
|
22
|
Bian EB, Li J and Zhao B: miR-29, a
potential therapeutic target for liver fibrosis. Gene. 544:259–260.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cicchini C, de Nonno V, Battistelli C,
Cozzolino AM, De Santis Puzzonia M, Ciafrè SA, Brocker C, Gonzalez
FJ, Amicone L and Tripodi M: Epigenetic control of EMT/MET
dynamics: HNF4α impacts DNMT3s through miRs-29. Biochim Biophys
Acta. 1849:919–929. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Zhang X, Li H, Yu J and Ren X: The
role of miRNA-29 family in cancer. Eur J Cell Biol. 92:123–128.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tsitoura E, Wells AU, Karagiannis K,
Lasithiotaki I, Vasarmidi E, Bibaki E, Koutoulaki C, Sato H,
Spandidos DA, Siafakas NM, et al: MiR-185/AKT and miR-29a/collagen
1a pathways are activated in IPF BAL cells. Oncotarget.
7:74569–74581. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lei GS, Kline HL, Lee CH, Wilkes DS and
Zhang C: Regulation of collagen V expression and
epithelial-mesenchymal transition by miR-185 and miR-186 during
idiopathic pulmonary fibrosis. Am J Pathol. 186:2310–2316. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu ZJ, Lu LG, Tao KZ, Chen DF, Xia Q, Weng
JJ, Zhu F, Wang XP and Zheng P: MicroRNA-185 suppresses growth and
invasion of colon cancer cells through inhibition of the hypoxia
inducible factor-2α pathway in vitro and in vivo. Mol
Med Rep. 10:2401–2408. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li S, Ma Y, Hou X, Liu Y, Li K, Xu S and
Wang J: MiR-185 acts as a tumor suppressor by targeting AKT1 in
non-small cell lung cancer cells. Int J Clin Exp Pathol.
8:11854–11862. 2015.PubMed/NCBI
|
|
29
|
Qadir XV, Han C, Lu D, Zhang J and Wu T:
miR-185 inhibits hepatocellular carcinoma growth by targeting the
DNMT1/PTEN/Akt pathway. Am J Pathol. 184:2355–2364. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding X, Yu C, Liu Y, Yan S, Li W, Wang D,
Sun L, Han Y, Li M, Zhang S, et al: Chronic obstructive sleep apnea
accelerates pulmonary remodeling via TGF-β/miR-185/CoLA1 signaling
in a canine model. Oncotarget. 7:57545–57555. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiao K, Luo X, Wang X and Gao Z: MicroRNA
185 regulates transforming growth factor β1 and collagen 1 in
hypertrophic scar fibroblasts. Mol Med Rep. 15:1489–1496. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang B, Li X, Ren Y, Wang J, Xu D, Hang Y,
Zhou T, Li F and Wang L: MicroRNA-29a regulates lipopolysaccharide
(LPS)-induced inflammatory responses in murine macrophages through
the Akt1/ NF-κB pathway. Exp Cell Res. 360:74–80. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li M, Li H, Liu X, Xu D and Wang F:
MicroRNA-29b regulates TGF-β1-mediated epithelial-mesenchymal
transition of retinal pigment epithelial cells by targeting AKT2.
Exp Cell Res. 345:115–124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park S, Hur JY, Lee KY, Lee JC, Rho JK,
Shin SH and Choi CM: Assessment of EGFR mutation status using
cell-free DNA from bronchoalveolar lavage fluid. Clin Chem Lab Med.
55:1489–1495. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Raghu G: Idiopathic pulmonary fibrosis:
Guidelines for diagnosis and clinical management have advanced from
consensus-based in 2000 to evidence-based in 2011. Eur Respir J.
37:743–746. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 World Health Organization
Classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Z, Xu Z, Sun S, Yu Y, Lv D, Cao C and
Deng Z: TGF-β1, IL-6, and TNF-α in bronchoalveolar lavage fluid:
Useful markers for lung cancer? Sci Rep. 4:55952014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kumar RK, O'Grady R, Maronese SE and
Wilson MR: Epithelial cell-derived transforming growth factor-beta
in bleomycin-induced pulmonary injury. Int J Exp Pathol. 77:99–107.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fernandez IE and Eickelberg O: The impact
of TGF-β on lung fibrosis: From targeting to biomarkers. Proc Am
Thorac Soc. 9:pp. 111–116. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Eser PO and Jänne PA: TGFβ pathway
inhibition in the treatment of non-small cell lung cancer.
Pharmacol Ther. Nov 10–2017.(Epub ahead of print). PubMed/NCBI
|
|
41
|
Shah MY, Ferrajoli A, Sood AK,
Lopez-Berestein G and Calin GA: microRNA therapeutics in cancer -
An emerging concept. EBioMedicine. 12:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hayashi M, Nomoto S, Hishida M, Inokawa Y,
Kanda M, Okamura Y, Nishikawa Y, Tanaka C, Kobayashi D, Yamada S,
et al: Identification of the collagen type 1 α 1 gene (COL1A1) as a
candidate survival-related factor associated with hepatocellular
carcinoma. BMC Cancer. 14:1082014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Oleksiewicz U, Liloglou T, Tasopoulou KM,
Daskoulidou N, Gosney JR, Field JK and Xinarianos G: COL1A1,
PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell
lung cancer. J Cancer Res Clin Oncol. 143:1133–1141. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li J, Ding Y and Li A: Identification of
COL1A1 and COL1A2 as candidate prognostic factors in gastric
cancer. World J Surg Oncol. 14:2972016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Selman M and Pardo A: Stochastic
age-related epigenetic drift in the pathogenesis of idiopathic
pulmonary fibrosis. Am J Respir Crit Care Med. 190:1328–1330. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Langevin SM, Pinney SM, Leung YK and Ho
SM: Does epigenetic drift contribute to age-related increases in
breast cancer risk? Epigenomics. 6:367–369. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT
and Wang YC: Alteration of DNA methyltransferases contributes to
5′CpG methylation and poor prognosis in lung cancer. Lung Cancer.
55:205–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jin B and Robertson KD: DNA
methyltransferases, DNA damage repair, and cancer. Adv Exp Med
Biol. 754:3–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen RZ, Pettersson U, Beard C,
Jackson-Grusby L and Jaenisch R: DNA hypomethylation leads to
elevated mutation rates. Nature. 395:89–93. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cushing L, Kuang P and Lü J: The role of
miR-29 in pulmonary fibrosis. Biochem Cell Biol. 93:109–118. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Misharin AV, Morales-Nebreda L, Reyfman
PA, Cuda CM, Walter JM, McQuattie-Pimentel AC, Chen CI, Anekalla
KR, Joshi N, Williams KJN, et al: Monocyte-derived alveolar
macrophages drive lung fibrosis and persist in the lung over the
life span. J Exp Med. 214:2387–2404. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Almatroodi SA, McDonald CF and Pouniotis
DS: Alveolar macrophage polarisation in lung cancer. Lung Cancer
Int. 2014:7210872014. View Article : Google Scholar : PubMed/NCBI
|
